Whistleblower Group

The Fraud Behind the Fraud of Off-Label Drug Marketing

By Gordon Schnell It has been one of the most common means for drug companies to get around what can be the very rigorous and time-consuming process of securing FDA approval for selling drugs.  That is, taking drugs that the FDA has approved as safe and effective for one particular use and marketing them to the medical community and the public for an entirely different set of uses.  This so-called off-label...

So You Think You Want to Be a Whistleblower -- A Few Words for the Wise

By Gordon Schnell, Marlene Koury and Jason Enzler

This is a gilded age for whistleblowers.  Relatively speaking that is.  It was not all that long ago that whistleblowers were treated as mere opportunists ratting out their friends or colleagues.  Squealing not for the greater good, but for a quick buck, or to cover up their own failings or misdeeds.  Many still see it that way.  Afterall, we are trained at an...

What is Going On With Big Pharma?

By Gordon Schnell With GlaxoSmithKline’s recent blockbuster $3 billion settlement with the Department of Justice -- the largest health care fraud penalty on record -- you have to wonder what is going on in the world of Big Pharma these days.  This is an industry that constantly complains of being misunderstood, underappreciated and unfairly maligned.  And there is some legitimacy to their lament.  Afterall,...

Johnson & Johnson’s Risperdal Woes Roll On

By Jason Enzler The hits keep coming for Johnson & Johnson.  On August 30, several state attorneys general announced that they have agreed to a $181 million settlement with Janssen Pharmaceuticals, a J & J subsidiary, regarding charges that the company was illegally promoting its antipsychotic drugs Risperdal and Invega.  Click here for a press release from New York.  The settlement, involving 36 states and the...

The IRS Whistleblower Office Gets Serious With Record Setting Award

By Gordon Schnell In a shot heard round the whistleblower world, the IRS has paid $104 million to former UBS banker Bradley Birkenfeld for blowing the whistle on the Swiss banking giant's scheme to help thousand of Americans cheat the IRS through secreting their assets in offshore accounts.  This is the scandal that led to the bank's payment of a $780 million fine and to the voluntary disclosure by more than...

To Report or Not Report; Conflicting Guidance From the Courts -- What is a Whistleblower to Do?

By Gordon Schnell and Marlene Koury (published in the American Banker) Under the recently implemented whistleblower provisions of the Dodd-Frank Act, whistleblowers who report violations of the securities laws are supposed to be protected from being fired.  These protections -- which can include reinstatement, double back pay and special damages -- are designed to serve as an incentive for whistleblowers to come...